Reverse payment of pharmaceutical products and pharmaceutical costs: interesting dilemma

United States Federal Trade Commission and members of Parliament "at least reverse payment, called '-of concept is contempt" to pay-of late "-pharmaceuticals. Recently such payments stop u.s. House of representatives, to restrict to reduce drug costs to consumers are expecting these benefits, 239-182 votes. Congressman wants to see their constituents to lower drug costs. Would significantly reduce the entry of generic drug prices everyone was expecting. To put some pressure on the generic brand companies, but in a significant percentage of their presence drug costs low. United States Federal Trade Commission, reverse pay about 3... 5 Billion forecast that can save us $ / year customer. May be these savings, but their efforts and annual u.s. drug income approx. 480 billion, compared to $ squabble value is not. These payments are less than the revenue per day. Is a part of for reverse payments using business to do so should all companies maximize the profits of patented drugs. These costs are passed to the consumer. Customers in the United States is covered with health plans do not know the price of prescription drugs. They pay for insurance. Legislation that reduces 12.11 drug costs. Fundamental reasons companies doing business in a profit. They will, if you set the rate of government restrictions or price, i.e. the highest revenue directly conflicts with the Charter for business of all. Discourage the Government price controls innovation is no sho-. Price / cost of need to understand the factors to be passed to the consumer be reduced, and how to lower the. Pay something to extend underlying the fact that all of us our lives is. Drug prices are based on emotion. The price is set at the top level corporate customers who can afford. Every company uses the emotion is the price of the supply chain. It also describes inefficiencies in business. Is the economic principles for limiting the profit. Teaching Economics and law in fair game, only competition can lower the price. If you need to grab market share to reveal fall in prices in developing countries to promote their selected recent brand companies price is low. In recent years, is not of prescription drugs with limited supply known merchandisers (4... $ 30-Day, 90-day supply is 10... $) From available. This can degrade drug prices, you can supply chain to its purpose benefit everyone with a clear indication. You need to promote the competition regulations and appropriate government agencies. You need to join this effort also supply chain companies. 8-10 Will value consumers to lower drug costs and they are passed to % more consumers. 1% Less than cost reduction value is none. Contrary to the "paid only" of like something to solve minor problems, not to achieve the ingredient's upsets placates and branded pharmaceutical company. To tackle the problem of actual drug costs, and to whom. Girish MALHOTRA, PEPresidentEPCOT international




View the Original article